Surgical Science completes the acquisition of Mimic Technologies
Surgical Science Sweden AB (publ) announced on January 20, 2021 that a conditional agreement to acquire all shares outstanding of Mimic Technologies Inc. (“Mimic”) with operations within the robotic surgery segment had been entered into. Mimic is based in Seattle, USA and through the acquisition Surgical Science further expands its customer base within the robotic surgery segment, gains access to technology for data collection/advanced analytics and strengthens its footprint in the highly important American market.
Surgical Science Sweden AB (publ) today, after all conditions precedent have been fulfilled, has completed the acquisition of all shares of Mimic Technologies Inc. and the dormant subsidiary Mimic Medical Education and Development LLC and thus controls 100% of the shares in the two companies. Both companies will be consolidated into Surgical Science upon closing of the acquisition.
Please refer to press releases dated January 20, 2021 for further details.
Gothenburg, 27 January 2021
Surgical Science Sweden AB (publ)
This press release, in its entirety, is available through the attachment or via:
https://surgicalscience.com/aktien/pressmeddelanden/
For further information, please contact:
Gisli Hennermark, CEO
Telephone: +46 70 420 83 00
E-mail: gisli.hennermark@surgicalscience.com
Anna Ahlberg, CFO
Telephone: +46 70 855 38 35
E-mail: anna.ahlberg@surgicalscience.com
The information was submitted for publication, through the agency of the contact persons above, on 27 January 2021 at 17:31 (CET).
This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.
About Surgical Science Sweden AB (publ)
One of the biggest challenges within healthcare globally is how injuries during care can be reduced. Medical education and training are key, as a large part of the training today can be performed outside the operating room. Surgical Science is a world leader in the manufacture of virtual reality simulators for evidence-based laparoscopic and endoscopic training. The simulators enable surgeons and other medical specialists to train and improve their psychomotor skills and instrument handling before entering the operating room. In parallel with its own products, Surgical Science works with simulation solutions for medical technology companies that develop surgical instruments for clinical use, such as robotic surgery.
Surgical Science is headquartered in Gothenburg, Sweden and present in Stockholm, Sweden. Through sales offices in the US, France, China and UAE as well as a global network of distributors, Surgical Science maintains a presence in most markets around the world. Surgical Science Sweden AB (publ) is traded on Nasdaq First North Growth Market. Certified Adviser is Erik Penser Bank (Telephone: 08-463 83 00; E-mail: certifiedadviser@penser.se).